United Therapeutics Corp
NASDAQ: UTHR
$234.06
-$3.87 (-1.6%)
Closing price April 22, 2024
Tuesday's top analyst upgrades and downgrades included CrowdStrike, Diamondback Energy, DoorDash, Etsy, JetBlue Airways, Lululemon Athletica, Marriott International and Silvergate Capital.
Published:
Tuesday's top analyst upgrades and downgrades included Adobe, Cheniere Energy, CNX Resources, Edwards Lifesciences, EOG Resources, Huntsman, Kraft Heinz, NCR, Peloton Interactive, PulteGroup,...
Published:
Tuesday's top analyst upgrades and downgrades included Accenture, Altria, American Airlines, APA, Bumble, Chevron, Datadog, General Motors, Mastercard, Pinduoduo, Regeneron Pharmaceuticals, Tesla,...
Published:
Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After all, many investors missed the bulk of the recovery from March’s panic...
Published:
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Cree, Etsy, Gilead Sciences, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems and Virgin Galactic.
Published:
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Published:
The top analyst upgrades, downgrades and initiations on Monday included Apple, Carnival, Generac, Lyft, Six Flags, Square, Tecnoglass, Yum! Brands, Western Digital and Zoetis.
Published:
The top analyst upgrades, downgrades and initiations seen on Thursday included American Eagle Outfitters, Atlassian, Match, NextEra Energy, Nordstom, Office Depot, Roku, Stamps.com and Tanger Factory...
Published:
The top analyst upgrades, downgrades and initiations seen on Tuesday included Alcoa, Apple, Autodesk, BB&T, Bed Bath & Beyond, Camping World, Nvidia, Vertex Pharmaceuticals and Voya Financial.
Published:
Last Updated:
Arena Pharmaceuticals shares jumped early on Thursday after the company announced a new global license agreement with United Therapeutics.
Published:
Last Updated:
MannKind shares are continuing their rally from Tuesday when it was announced that United Therapeutics was licensing MannKind a dry powder formulation of treprostinil, the active ingredient in...
Published:
Last Updated:
SteadyMed saw its shares skyrocket early on Monday after the company announced that it would be acquired by United Therapeutic.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include AngioDynamics, Commercial Metals, Eldorado Resorts, Gamestop, Marvell Technology, Spotify and U.S. Steel.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include Callaway Golf, Capital One, Sarepta Therapeutics, Tesla, UnitedHealth and Wayfair.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations include ConocoPhillips, Goodyear Tire, Humana, Lululemon Athletica and Range Resources.
Published:
Last Updated: